Controlled Substances Prescribing Authority for Physician Assistants
Physician Assistants (PAs) can prescribe Schedule II-V controlled substances, but their authority varies by state law and may require physician supervision, delegation, or collaboration depending on the state's regulations. 1
Federal Classification of Controlled Substances
Controlled substances are categorized into schedules based on their potential for abuse:
Schedule II: High potential for abuse with severe psychological or physical dependence
- Examples: Morphine, oxycodone, hydromorphone, fentanyl, methadone, hydrocodone
- Requires DEA registration and appropriate state authority
Schedule III: Moderate to low potential for abuse
- Examples: Combination products containing ≤15mg hydrocodone with acetaminophen 2
- Buprenorphine (requires special DEA waiver)
Schedule IV: Low potential for abuse
- Examples: Benzodiazepines, tramadol, zolpidem
Schedule V: Lowest potential for abuse
- Examples: Certain cough preparations with limited amounts of codeine
State-Specific Considerations
The ability of PAs to prescribe controlled substances is determined by:
State laws and regulations: Each state has different requirements regarding:
- Level of physician supervision required
- Types of controlled substances PAs can prescribe
- Quantity limitations
- Refill restrictions
DEA registration: PAs must obtain their own DEA registration to prescribe controlled substances
Practice agreements: Many states require formal agreements with supervising physicians that may specify:
- Which controlled substances can be prescribed
- Circumstances under which they can be prescribed
- Documentation and consultation requirements
Common Limitations and Requirements
Supervision requirements:
- Some states require direct supervision
- Others allow more autonomous practice with collaborative agreements
- A few states grant independent prescribing authority
Schedule II restrictions:
- Some states limit the duration of Schedule II prescriptions by PAs
- May require more frequent physician consultation for Schedule II medications
- Some states prohibit PA prescribing of certain Schedule II medications
Special circumstances:
- Buprenorphine for opioid use disorder requires additional DEA waiver (X-waiver) 3
- Some states have additional restrictions for prescribing to patients with chronic pain
Best Practices for PA Prescribing
Know your state laws: Maintain current knowledge of state-specific regulations
Maintain proper documentation:
- Document medical necessity
- Record assessment of risk for abuse
- Document informed consent discussions
Follow evidence-based guidelines:
- Use appropriate screening tools
- Implement risk mitigation strategies
- Consider non-opioid alternatives when appropriate
Monitoring requirements:
- Use prescription drug monitoring programs (PDMPs)
- Conduct urine drug testing when appropriate
- Schedule regular follow-up visits
Common Pitfalls to Avoid
Exceeding state-authorized scope: Prescribing beyond what state law permits
Inadequate documentation: Failing to document medical necessity and risk assessment
Ignoring red flags: Missing signs of medication misuse or diversion
Failing to check PDMPs: Not utilizing state prescription monitoring databases
Inappropriate prescribing patterns: PAs should be aware that studies have identified some concerning patterns of higher-frequency, high-dose opioid prescribing among a small subset of NPs and PAs compared to physicians 4
PAs must stay current with both federal and state regulations regarding their prescribing authority, as these laws frequently change and vary significantly between states. Maintaining proper documentation and following evidence-based guidelines are essential for appropriate prescribing of controlled substances.